Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Search Results
Overall search
Search ClinicalINFO
Search Results
3141 – 3160
of
3979
Introduction
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/introduction
Poor CD4 Cell Recovery and Persistent Inflammation Despite Viral Suppression
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/poor-cd4-cell-recovery-and-persistent
Hepatitis C Virus/HIV Coinfection
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/coinfections-hepatitis-c-virus-hcv
Raltegravir (Isentress, Isentress HD, RAL)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-raltegravir-isentress
Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors
https://clinicalinfo.hiv.gov/guidelines/perinatal/nucleoside-and-nucleotide-analogue-reverse-transcriptase-inhibitors
Drug-Drug Interactions
https://clinicalinfo.hiv.gov/guidelines/adult-and-adolescent-arv/drug-drug-interactions
Drug-Drug Interactions: Protease Inhibitors and Other Drugs
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-protease-inhibitors
Drug-Resistance Testing and Use of Drug-Resistance Assays
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-resistance-testing-and-use-drug
Diagnosis of HIV Infection in Infants and Children
https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-diagnosis-hiv-infection-children
Appendix B: Community-Acquired Pneumonia
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-b-3
Introduction
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/introduction
HLA-B* 5701 Screening
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/hla-b-5701-screening
Introduction
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/introduction
Saquinavir (Invirase, SQV)
https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-saquinavir-invirase
Drug-Drug Interactions: Integrase Strand Transfer Inhibitors and Other Drugs
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-insti
Bacterial Enteric Infections
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/bacterial-enteric
Discontinuation or Interruption of Antiretroviral Therapy
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/discontinuation-or-interruption
Cryptosporidiosis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/cryptosporidiosis
Cystoisosporiasis (Formerly Isosporiasis)
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/cystoisosporiasis
Fixed-Dose Combinations
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/fixed-dose-combinations
Pagination
First page
«
Previous page
‹
…
Page
154
Page
155
Page
156
Page
157
Current page
158
Page
159
Page
160
Page
161
Page
162
…
Next page
›
Last page
»